Language selection

Government of Canada / Gouvernement du Canada

Search

Respiratory Virus Report, Week 13 - ending March 30, 2024

Download in PDF format
(898 KB, 13 pages)

Organization: Public Health Agency of Canada

Please note that the Respiratory Virus Detection Surveillance System (RVDSS) is a sentinel laboratory surveillance system that does not capture all respiratory virus testing performed in Canada; differences may exist between the data presented in this report and provincial/territorial epidemiological reports. SARS-CoV-2 laboratory data is included in this report to facilitate the comparison of positivity with other respiratory viruses. Interpretation should be made with caution as testing practices differ among viruses.

For additional SARS-CoV-2 surveillance information, please refer to the COVID-19 epidemiology update.

Overall summary

In week 13 (week ending March 30, 2024) in Canada, participating RVDSS laboratories reported 1,438 detections of SARS-CoV-2 from 29,526 tests (4.9% positive). Among non-SARS-CoV-2 respiratory viruses, where test volumes are lower (range of 7,176 to 27,703 tests), activity of influenza is highest.

  • National SARS-CoV-2 percent positivity has been decreasing since mid-December 2023.
  • Influenza A percent positivity has decreased in recent weeks (742 detections; 2.7% positive) and is lower than influenza B which is currently increasing (1,814 detections; 6.6% positive).
  • RSV percent positivity has decreased in recent weeks (556 detections; 2.3% positive).
  • Percent positivity of all other non-SARS-CoV-2 respiratory viruses is within expected levels typical of this time of year.
  • 35/35 sentinel laboratories reported surveillance data

On this page

Abbreviations:
ADV
Adenovirus
Atl
Atlantic Canada
BC
British Columbia
Can
Canada
EORLA
Eastern Ontario Regional Laboratory Association
EV/RV
Enterovirus/Rhinovirus
Flu
Influenza
Flu A(H1)pdm09
Influenza A(H1N1)pdm09
Flu A(H3)
Influenza A(H3N2)
Flu A(UnS)
Influenza A(Unsubtyped)
HCoV
Human coronavirus 229E/OC43/NL63/HKU1
HMPV
Human metapneumovirus
HPIV
Human parainfluenza virus
HSC
Health Sciences Centre
N.C.
Data not collected
N.R.
Data not reported for current week
ON
Ontario
PR
Prairies
P.H.O.L.
Public Health Ontario Laboratory
QC
Quebec
RSV
Respiratory syncytial virus
RVDSS
Respiratory Virus Detection Surveillance System
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Terr
Territories of Canada
UHN
University Health Network

Respiratory virus detections

Table 1: Respiratory virus detections for the week ending March 30, 2024 (surveillance week 2024-13)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 533 59 401 0 0 6 6 18 401 25 401 0 2 9 1 0 401 5 401 30 401 17 401 32
Prince Edward Island 214 15 201 0 0 3 3 46 201 4 15 0 0 2 0 0 15 1 15 0 15 2 15 0
Nova Scotia 1217 81 1215 0 0 80 80 38 948 17 26 0 0 0 0 0 26 1 26 2 26 2 26 1
New Brunswick 867 39 1092 0 0 22 22 109 1092 37 139 0 0 7 2 0 139 5 139 11 139 29 139 5
Atlantic 2831 194 2909 0 0 111 111 211 2642 83 581 0 2 18 3 0 581 12 581 43 581 50 581 38
Région Nord-Est 1267 36 1398 0 0 15 15 125 634 35 88 0 0 6 0 0 88 5 84 6 N.C. N.C. 88 8
Québec-Chaudière-Appalaches 1185 16 1315 0 0 46 46 152 1235 74 438 0 0 1 1 0 460 13 438 29 N.C. N.C. 306 10
Centre-du-Québec 1806 52 1752 0 0 92 92 104 810 32 23 0 0 2 0 0 23 1 23 2 N.C. N.C. 25 0
Montréal-Laval 2082 64 2788 0 0 75 75 132 1630 55 825 1 0 35 0 0 825 22 825 55 N.C. N.C. 825 43
Ouest du Québec 1009 28 663 0 0 48 48 38 654 14 22 0 0 5 0 0 22 0 22 2 N.C. N.C. 22 2
Montérégie 1188 34 1418 0 0 46 46 55 1417 27 3 0 0 0 0 0 3 0 3 0 N.C. N.C. 3 0
Province of Québec 8537 230 9334 0 0 322 322 606 6380 237 1399 1 0 49 1 0 1421 41 1395 94 N.C. N.C. 1269 63
P.H.O.L. - Ottawa 221 45 215 6 0 0 6 5 215 2 129 0 0 0 0 15 129 0 129 10 129 3 129 17
EORLA 853 52 549 0 0 17 17 53 549 5 47 0 0 5 0 0 47 1 47 4 47 5 47 1
P.H.O.L. - Kingston 139 24 111 1 0 0 1 1 111 0 66 0 0 0 0 2 66 0 66 2 66 2 66 22
UHN / Mount Sinai Hospital 897 17 620 0 0 8 8 4 620 5 70 0 0 1 0 0 70 1 70 0 70 4 70 0
P.H.O.L. - Toronto 229 23 809 20 1 5 24 15 809 1 801 0 0 0 0 68 801 5 801 57 801 52 801 79
Sick Kids Hospital - Toronto 116 2 117 0 1 0 1 8 117 1 117 0 0 8 0 0 117 5 117 10 117 28 117 4
Shared Hospital Laboratory 1626 25 1298 16 2 4 22 34 1298 3 1286 0 0 0 0 20 1286 11 1297 17 1297 19 1297 22
P.H.O.L. - Sault Ste. Marie 16 10 22 2 0 0 2 0 22 0 12 0 0 0 0 0 12 0 12 0 12 0 12 0
P.H.O.L. - Timmins 22 0 32 0 0 0 0 2 32 1 28 0 0 0 0 3 28 0 28 1 28 0 28 6
St. Joseph's - London 740 19 574 0 0 4 4 16 574 1 73 0 0 0 0 8 73 1 73 1 73 9 73 3
P.H.O.L. - London 224 13 210 1 0 7 8 5 210 1 198 0 0 0 0 16 198 1 198 12 198 31 198 16
P.H.O.L. - Orillia 4 0 4 0 0 0 0 0 4 0 4 0 0 0 0 0 4 0 4 1 4 0 4 0
P.H.O.L. - Thunder Bay 32 3 23 0 0 1 1 0 23 0 11 0 0 0 0 0 11 0 11 0 11 0 11 2
P.H.O.L. - Sudbury 14 0 26 2 0 1 3 0 26 2 25 0 0 0 0 2 25 0 25 0 25 0 25 9
P.H.O.L. - Hamilton 126 10 146 7 1 10 17 3 146 0 121 0 0 0 0 5 121 4 121 15 121 8 121 16
P.H.O.L. - Peterborough 38 0 49 0 0 3 3 0 49 0 28 0 0 0 0 4 28 2 28 8 28 4 28 1
St. Joseph's - Hamilton 1543 48 1478 0 0 36 36 63 1478 10 1478 0 0 51 0 0 1478 8 1478 73 1478 65 0 0
Sault Area Hospital 122 7 101 2 1 0 3 1 101 5 80 0 0 2 0 0 80 1 80 6 80 6 80 4
Province of Ontario 6962 298 6384 57 6 96 156 210 6384 37 4574 0 0 67 0 143 4574 40 4585 217 4585 236 3107 202
Manitoba 1280 85 1092 1 0 14 15 74 1092 24 75 0 0 1 0 0 75 1 83 8 75 7 83 7
Saskatchewan 1750 84 1348 0 0 35 35 214 1092 41 420 0 0 18 2 0 420 2 420 16 420 33 420 20
Alberta 4440 210 4230 24 5 2 39 403 4070 70 1028 3 0 46 0 0 1028 10 941 1 1012 105 1028 48
Prairies 7470 379 6670 25 5 51 89 691 6254 135 1523 3 0 65 2 0 1523 13 1444 25 1507 145 1531 75
British Columbia 3454 317 2178 23 15 2 62 47 2052 41 704 1 3 32 3 0 704 34 704 59 688 100 688 44
Yukon 31 0 22 0 0 0 0 0 22 0 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 25 3 23 0 0 0 0 1 23 0 N.C. N.C. N.C. N.C. N.C. N.C. 23 0 23 0 23 2 N.C. N.C.
Nunavut 216 17 183 1 1 0 2 48 183 23 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 272 20 228 1 1 0 2 49 228 23 N.C. N.C. N.C. N.C. N.C. N.C. 23 0 23 0 23 2 N.C. N.C.
CANADA 29526 1438 27703 106 27 582 742 1814 23940 556 8781 5 5 231 9 143 8826 140 8732 438 7384 533 7176 422

The data in the RVDSS report represent surveillance data available at the time of writing. Data missing from the current week are denoted by N.R. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively.

Table 2: Cumulative respiratory virus detections from August 27, 2023 to March 30, 2024 (surveillance weeks 2023-35 to 2024-13)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 19228 2816 14064 0 0 1319 1319 101 14064 913 14064 16 67 40 101 0 14064 235 14064 288 14064 1114 14064 364
Prince Edward Island 7210 773 4660 0 0 541 541 196 4660 363 512 3 0 6 8 0 511 29 501 16 511 125 495 24
Nova Scotia 44482 8338 30947 0 0 2605 2605 337 25535 1402 1080 16 3 4 10 0 1080 40 1073 10 1080 220 1079 16
New Brunswick 33951 3851 31777 889 25 1894 2808 666 31373 1846 2823 7 4 20 30 0 2823 105 2823 73 2823 546 2823 116
Atlantic 104871 15778 81448 889 25 6359 7273 1300 75632 4524 18479 42 74 70 149 0 18478 409 18461 387 18478 2005 18461 520
Région Nord-Est 52541 7045 47624 5 0 4712 4717 634 18899 1392 2427 16 12 25 16 0 2427 104 2370 93 N.C. N.C. 2427 104
Québec-Chaudière-Appalaches 61514 9295 41272 0 0 5464 5464 1186 39584 2626 15723 22 9 29 14 0 16209 499 15723 466 N.C. N.C. 12890 419
Centre-du-Québec 76652 12400 38129 0 0 4471 4471 723 22393 1592 1137 15 8 19 7 0 1137 56 1137 51 N.C. N.C. 1168 43
Montréal-Laval 91936 13870 75838 5 2 6554 6561 523 48793 2847 25790 95 40 226 24 0 25790 503 25860 590 N.C. N.C. 25790 891
Ouest du Québec 50497 10018 21644 4 0 2055 2059 259 21432 1092 598 11 3 18 7 0 598 43 598 19 N.C. N.C. 598 28
Montérégie 49049 8009 40008 0 0 3186 3186 275 38931 1760 213 1 0 0 1 0 213 7 213 3 N.C. N.C. 213 3
Province of Québec 382189 60637 264515 14 2 26442 26458 3600 190032 11309 45888 160 72 317 69 0 46374 1212 45901 1222 N.C. N.C. 43086 1488
P.H.O.L. - Ottawa 10628 3721 7402 290 54 184 405 33 7396 132 4417 0 0 0 0 117 4417 13 4415 85 4417 421 4415 245
EORLA 39327 4499 18437 0 0 1576 1576 345 18437 1120 1215 2 5 26 4 0 1190 14 1215 29 1215 219 1215 37
P.H.O.L. - Kingston 7273 2073 4103 132 19 96 221 5 4103 168 2869 0 0 0 0 65 2869 11 2869 24 2869 330 2869 117
UHN / Mount Sinai Hospital 33711 3016 21099 41 10 540 591 72 21099 224 1339 0 0 19 2 0 1339 3 1339 7 1339 64 1339 43
P.H.O.L. - Toronto 18492 5420 33691 1166 907 342 1765 230 33682 1044 30917 0 0 0 0 1022 30925 359 30902 644 30917 2872 30902 1542
Sick Kids Hospital - Toronto 3959 307 3565 105 99 20 224 52 3565 310 3565 15 12 80 21 0 3565 97 3565 103 3565 635 3565 107
Shared Hospital Laboratory 54076 4533 45515 846 520 291 1657 358 45522 1338 45292 0 0 0 0 309 39638 330 45369 252 45414 1468 45391 516
P.H.O.L. - Sault Ste. Marie 452 198 552 52 3 16 65 1 552 45 384 0 0 0 0 5 384 1 384 0 384 21 384 38
P.H.O.L. - Timmins 1109 325 1102 58 10 30 87 7 1102 62 871 0 0 0 0 25 871 4 871 9 871 52 871 37
St. Joseph's - London 27420 3463 14953 0 0 965 965 210 14953 712 2080 0 0 0 0 34 2099 33 2099 32 2101 236 2099 58
P.H.O.L. - London 14261 4104 10596 483 141 168 607 90 10593 470 8519 0 0 0 0 248 8519 37 8517 107 8519 747 8517 333
P.H.O.L. - Orillia 554 144 1241 71 17 11 99 0 1238 74 1176 0 0 0 0 31 1176 16 1176 19 1176 145 1176 24
P.H.O.L. - Thunder Bay 1816 501 1132 57 0 9 38 5 1129 30 942 0 0 0 0 27 942 6 942 29 942 57 942 27
P.H.O.L. - Sudbury 715 239 858 42 1 23 66 1 856 25 610 0 0 0 0 21 611 1 610 8 610 47 610 50
P.H.O.L. - Hamilton 7061 2106 5840 149 66 97 257 37 5839 172 4402 0 0 0 0 140 4402 84 4401 111 4402 561 4401 207
P.H.O.L. - Peterborough 2252 666 2298 206 204 73 153 24 2288 221 1809 0 0 0 0 65 1809 38 1809 43 1809 289 1809 54
St. Joseph's - Hamilton 58996 5793 52463 0 0 3162 3162 646 52463 1762 52463 0 0 467 0 0 52463 330 52463 634 52463 2991 0 0
Sault Area Hospital 5805 782 3910 176 18 55 249 15 3903 203 3066 27 0 20 17 0 3017 36 3017 25 3017 257 3027 67
Province of Ontario 287907 41890 228757 3874 2069 7658 12187 2131 228720 8112 165936 44 17 612 44 2109 160236 1413 165963 2161 166030 11412 113532 3502
Manitoba 50134 7228 37721 144 12 1841 1997 375 37721 1353 2891 2 10 22 41 0 2891 122 3667 143 2891 526 3667 130
Saskatchewan 64408 7300 44017 117 10 5408 5535 1521 39368 1561 14229 30 9 93 25 0 14229 273 14229 763 14229 1354 14229 359
Alberta 167787 19698 146246 11772 749 584 13181 3081 136568 6080 40212 135 91 495 3 0 40201 469 38917 30 39577 3630 40211 999
Prairies 282329 34226 227984 12033 771 7833 20713 4977 213657 8994 57332 167 110 610 69 0 57321 864 56813 936 56697 5510 58107 1488
British Columbia 118747 15893 118824 4050 801 260 8564 940 115939 5801 27929 115 177 303 179 0 27931 867 27816 1095 26819 4079 26796 816
Yukon 1659 178 1086 34 15 0 60 5 1077 46 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 1172 75 1110 166 6 1 173 48 1110 168 N.C. N.C. N.C. N.C. N.C. N.C. 911 44 911 9 1110 133 N.C. N.C.
Nunavut 4222 358 3004 432 33 52 517 156 3004 453 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 7053 611 5200 632 54 53 750 209 5191 667 N.C. N.C. N.C. N.C. N.C. N.C. 911 44 911 9 1110 133 N.C. N.C.
CANADA 1183096 169035 926728 21492 3722 48605 75945 13157 829171 39407 315564 528 450 1912 510 2109 311251 4809 315865 5810 269134 23139 259982 7814

The data in the RVDSS report represent surveillance data available at the time of writing. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively. Due to these delays, the sum of weekly report totals do not add up to cumulative totals.

Positive respiratory virus tests historical comparison

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 1

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: SARS-CoV-2 surveillance was integrated into RVDSS at the beginning of the 2022-2023 season; no prior data is available for historical comparison.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 SARS-CoV-2% 2022-2023 SARS-CoV-2% 2023-2024 A% 2022-2023 A% 2021-2022 A% Max A% Base Min A% Base Av A% Base 2023-2024 B% 2022-2023 B% 2021-2022 B% Max B% Base Min B% Base Av B% Base 2023-2024 RSV% 2022-2023 RSV% 2021-2022 RSV% Max RSV% Base Min RSV% Base Av RSV% Base
35 2023-09-02 14.40 13.40 0.69 0.18 0.04 1.60 0.11 0.67 0.06 0.02 0.00 0.28 0.00 0.14 0.58 1.12 4.43 1.34 0.38 0.61
36 2023-09-09 15.92 13.07 0.43 0.14 0.01 2.11 0.23 0.99 0.06 0.04 0.00 0.55 0.00 0.15 0.71 1.12 6.61 1.09 0.22 0.62
37 2023-09-16 16.49 12.74 0.48 0.23 0.03 1.59 0.35 0.87 0.03 0.01 0.00 0.19 0.04 0.12 0.82 1.06 7.59 1.37 0.38 0.65
38 2023-09-23 18.60 13.62 0.51 0.48 0.00 2.15 0.43 1.17 0.02 0.02 0.00 0.21 0.00 0.14 1.15 1.47 7.16 1.24 0.37 0.67
39 2023-09-30 19.59 14.44 0.51 0.67 0.01 2.65 0.50 1.52 0.09 0.03 0.00 0.29 0.09 0.18 1.14 2.14 8.48 1.29 0.51 0.72
40 2023-10-07 19.81 15.06 0.64 0.96 0.00 2.17 1.01 1.58 0.05 0.03 0.02 0.20 0.05 0.11 1.35 2.54 8.53 1.39 0.34 0.71
41 2023-10-14 17.55 16.59 0.49 1.42 0.03 2.66 1.05 1.56 0.03 0.01 0.03 0.36 0.03 0.16 1.80 3.65 9.54 1.74 0.58 1.03
42 2023-10-21 17.78 15.39 0.73 2.36 0.03 2.96 0.77 1.92 0.08 0.05 0.02 0.45 0.05 0.25 2.38 4.63 8.18 2.11 0.63 1.25
43 2023-10-28 17.89 15.78 1.16 5.47 0.03 5.19 0.68 2.59 0.10 0.03 0.02 0.55 0.06 0.23 3.25 6.76 8.11 2.16 0.55 1.41
44 2023-11-04 17.74 13.91 2.63 10.75 0.10 8.32 1.08 3.35 0.10 0.03 0.10 0.71 0.12 0.31 4.07 7.77 7.82 3.35 0.83 2.07
45 2023-11-11 18.17 12.43 4.93 16.19 0.07 9.83 1.18 4.19 0.14 0.04 0.06 0.97 0.22 0.44 5.12 7.68 7.03 4.43 1.29 2.71
46 2023-11-18 18.80 11.96 7.24 20.23 0.10 13.89 1.42 5.43 0.16 0.05 0.06 1.49 0.09 0.57 5.85 7.54 7.18 6.33 1.38 3.60
47 2023-11-25 19.31 11.76 8.81 24.27 0.13 15.25 1.25 6.91 0.12 0.04 0.07 2.13 0.13 0.80 6.81 6.66 8.10 8.69 1.79 4.79
48 2023-12-02 18.03 12.12 11.62 24.04 0.19 18.07 0.76 9.40 0.26 0.03 0.15 3.18 0.08 1.20 6.99 6.87 8.92 9.47 3.11 6.08
49 2023-12-09 17.53 12.61 14.74 21.12 0.23 19.13 1.43 11.34 0.29 0.06 0.05 4.21 0.19 1.60 7.38 7.29 10.09 12.26 5.40 7.54
50 2023-12-16 17.78 13.10 15.32 17.31 0.23 26.42 1.97 13.93 0.36 0.06 0.02 7.50 0.15 2.48 7.26 8.61 10.78 13.19 6.42 8.55
51 2023-12-23 16.81 14.09 16.78 12.50 0.18 28.53 2.27 16.69 0.45 0.05 0.02 10.44 0.19 3.30 7.29 9.16 8.97 15.23 7.40 9.92
52 2023-12-30 15.35 15.53 18.18 7.93 0.09 33.97 3.30 20.32 0.52 0.07 0.01 12.58 0.23 4.04 7.41 10.59 6.72 17.80 7.89 10.97
1 2024-01-06 14.51 15.03 14.49 4.54 0.08 30.93 4.58 19.59 0.60 0.07 0.00 10.34 0.22 3.87 7.10 10.34 5.26 15.62 8.37 10.84
2 2024-01-13 13.03 13.38 11.16 2.21 0.11 26.80 5.46 19.11 0.56 0.05 0.01 11.01 0.29 3.91 6.26 9.07 4.32 14.05 7.45 10.24
3 2024-01-20 11.35 12.21 10.27 1.40 0.04 28.20 9.13 18.95 0.79 0.14 0.01 12.75 0.35 4.70 6.13 8.43 3.42 15.56 7.90 10.95
4 2024-01-27 10.19 11.30 11.10 0.91 0.05 27.01 12.34 18.82 1.08 0.14 0.00 12.74 0.41 5.17 5.85 7.96 2.33 15.88 8.38 11.89
5 2024-02-03 9.34 11.51 11.28 0.76 0.03 23.66 15.78 19.15 1.48 0.28 0.01 14.84 0.41 5.77 5.91 7.15 2.19 16.33 8.77 12.14
6 2024-02-10 8.79 11.88 10.37 0.67 0.04 23.36 15.68 18.80 1.74 0.34 0.01 16.23 0.44 6.22 5.21 5.78 2.10 15.79 7.98 12.32
7 2024-02-17 8.12 11.79 9.43 0.57 0.02 24.22 15.48 18.53 2.18 0.29 0.00 17.02 0.35 6.56 4.49 5.13 2.16 15.53 8.42 11.89
8 2024-02-24 7.49 11.73 8.01 0.57 0.06 28.62 12.42 18.57 3.17 0.49 0.02 16.79 0.45 6.61 4.78 4.53 2.12 15.47 8.04 11.28
9 2024-03-02 7.03 11.18 6.72 0.63 0.12 29.30 11.04 18.13 4.03 0.70 0.00 15.45 0.74 6.25 3.79 3.70 2.50 15.62 7.59 10.52
10 2024-03-09 6.24 11.41 5.55 0.63 0.16 29.65 8.51 16.84 5.12 0.77 0.00 14.86 0.81 6.42 3.64 2.80 3.10 14.97 6.92 9.92
11 2024-03-16 6.13 11.58 4.36 0.52 0.26 24.27 6.74 14.55 5.42 1.15 0.01 13.11 1.05 6.86 3.18 2.18 3.71 12.11 6.29 9.33
12 2024-03-23 5.17 11.28 3.27 0.59 0.86 20.91 5.51 12.68 5.71 1.29 0.00 11.53 1.51 7.43 2.44 1.98 3.79 10.70 6.46 8.59
13 2024-03-30 4.87 10.85 2.68 0.64 1.52 18.09 4.67 11.66 6.55 1.72 0.00 12.55 1.98 7.90 2.32 1.63 4.00 9.32 6.45 8.11
Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 2

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Note: % Tests Positive scale changes across the dashed line

Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 EV/RV% 2022-2023 EV/RV% 2021-2022 EV/RV% Max EV/RV% Base Min EV/RV% Base Av EV/RV% Base 2023-2024 HPIV% 2022-2023 HPIV% 2021-2022 HPIV% Max HPIV% Base Min HPIV% Base Av HPIV% Base 2023-2024 ADV% 2022-2023 ADV% 2021-2022 ADV% Max ADV% Base Min ADV% Base Av ADV% Base 2023-2024 HMPV% 2022-2023 HMPV% 2021-2022 HMPV% Max HMPV% Base Min HMPV% Base Av HMPV% Base 2023-2024 HCoV% 2022-2023 HCoV% 2021-2022 HCoV% Max HCoV% Base Min HCoV% Base Av HCoV% Base
35 2023-09-02 12.50 15.47 21.96 27.19 22.44 24.71 1.99 2.80 5.99 3.16 1.15 2.44 1.62 2.28 1.18 1.74 0.99 1.43 0.34 1.80 0.23 2.04 0.10 0.78 0.28 0.53 1.05 0.76 0.18 0.45
36 2023-09-09 14.85 16.22 18.59 30.69 23.30 26.31 1.49 3.21 4.93 3.31 1.35 2.32 1.52 2.18 1.15 2.85 1.42 1.87 0.39 1.81 0.24 0.84 0.10 0.48 0.42 0.38 0.62 0.38 0.12 0.22
37 2023-09-16 18.29 21.73 27.46 33.58 27.74 31.69 1.60 3.02 5.97 3.26 1.65 2.40 1.47 2.10 0.81 2.44 1.38 1.86 0.39 1.38 0.17 1.61 0.00 0.51 0.23 0.28 0.44 0.56 0.00 0.26
38 2023-09-23 20.25 23.50 33.19 39.57 32.80 35.83 1.77 2.42 4.73 2.87 1.92 2.33 0.93 1.58 0.82 2.04 1.11 1.63 0.38 1.61 0.37 1.43 0.06 0.48 0.46 0.32 0.67 1.36 0.06 0.43
39 2023-09-30 18.52 22.89 30.01 40.59 34.87 37.68 1.32 3.09 8.12 3.01 1.70 2.24 1.15 2.21 1.14 2.27 1.04 1.66 0.51 1.43 0.17 0.72 0.05 0.29 0.28 0.59 0.62 0.66 0.07 0.45
40 2023-10-07 17.45 19.32 26.26 41.29 33.00 35.43 1.34 3.69 8.19 3.28 1.90 2.43 1.41 1.79 1.31 2.25 1.39 1.82 0.32 1.49 0.16 0.92 0.05 0.34 0.26 0.93 0.57 1.08 0.22 0.59
41 2023-10-14 15.74 16.70 22.91 33.62 26.94 29.93 1.28 3.52 10.46 3.70 1.96 2.75 1.38 2.03 1.37 1.91 1.28 1.70 0.37 1.66 0.20 0.95 0.04 0.46 0.32 0.99 1.69 0.70 0.00 0.34
42 2023-10-21 13.12 12.95 22.16 32.62 24.54 27.86 1.59 4.22 10.01 3.89 2.64 3.21 1.43 1.65 2.54 2.39 1.47 1.86 0.46 1.58 0.15 0.89 0.15 0.40 0.17 1.16 1.07 1.18 0.20 0.49
43 2023-10-28 12.52 11.05 19.64 28.73 21.67 24.95 1.21 4.41 9.38 3.98 3.18 3.54 1.48 1.79 1.15 2.42 1.63 1.96 0.46 1.79 0.36 1.64 0.12 0.58 0.38 1.86 1.05 2.35 0.27 0.75
44 2023-11-04 10.83 10.23 21.45 23.82 16.75 21.38 1.44 4.14 10.28 4.81 2.94 3.72 1.76 2.02 1.42 2.88 1.18 2.21 0.55 1.79 0.77 1.08 0.23 0.48 0.37 2.54 2.21 2.59 0.21 0.88
45 2023-11-11 10.70 7.77 22.39 23.08 15.17 20.56 1.65 3.90 9.97 5.42 2.53 4.01 1.45 1.99 1.63 2.68 2.02 2.42 0.60 2.06 0.64 1.30 0.04 0.77 0.42 3.00 2.57 2.74 0.52 0.96
46 2023-11-18 8.64 6.93 21.37 22.77 15.28 19.24 1.39 3.97 8.29 5.72 1.62 4.14 2.03 1.87 2.51 2.90 1.99 2.52 0.79 1.89 0.99 1.43 0.18 0.81 0.65 3.54 2.99 3.32 0.46 1.25
47 2023-11-25 7.62 4.88 18.54 20.84 12.15 16.09 1.55 3.63 7.04 7.00 2.36 4.72 1.90 1.89 1.94 2.95 1.83 2.35 1.00 1.78 1.01 2.02 0.09 0.90 0.65 3.24 3.90 3.26 0.37 1.25
48 2023-12-02 6.79 4.74 16.64 16.72 12.69 13.84 1.51 3.04 5.78 6.14 3.03 4.18 2.15 1.87 1.89 3.34 1.66 2.49 0.91 1.86 1.48 1.94 0.31 1.09 0.76 3.94 4.94 4.30 1.00 2.04
49 2023-12-09 6.00 4.09 14.57 16.32 10.72 13.07 1.39 3.03 3.97 5.65 2.94 4.19 1.83 1.68 2.48 3.03 1.84 2.50 1.20 1.93 1.22 2.80 0.49 1.48 1.12 4.48 6.58 5.19 0.84 2.53
50 2023-12-16 5.90 4.58 12.40 13.85 8.43 10.91 1.46 2.98 3.23 5.95 2.54 4.22 2.00 2.29 2.72 3.13 1.49 2.42 1.31 1.92 1.08 3.32 0.46 1.68 1.47 5.13 7.26 6.04 1.54 3.16
51 2023-12-23 5.56 4.49 9.95 14.18 8.81 10.48 1.35 3.09 3.01 6.71 2.94 3.95 1.55 1.76 2.54 3.20 1.36 2.04 1.59 2.23 1.20 4.39 0.37 2.47 1.77 5.28 8.11 6.68 1.87 3.72
52 2023-12-30 4.71 4.50 7.71 14.41 6.24 9.26 1.35 3.32 2.13 5.08 2.87 3.75 1.76 1.80 1.92 2.59 1.20 1.76 1.76 2.75 1.00 3.81 0.41 2.49 2.48 4.73 10.33 6.73 2.78 4.73
1 2024-01-06 4.80 4.19 5.71 11.09 4.36 7.42 1.48 3.63 1.84 5.08 2.68 3.34 1.48 1.88 1.84 2.67 0.85 1.54 2.20 2.94 0.72 4.45 0.28 2.74 3.06 4.40 9.27 7.77 3.07 5.16
2 2024-01-13 4.43 4.71 3.98 9.55 4.31 6.79 1.17 3.24 1.19 4.12 2.46 3.05 1.25 1.87 1.13 2.15 0.87 1.37 1.64 2.61 0.38 4.76 0.42 2.69 3.19 4.01 7.46 7.89 2.84 5.45
3 2024-01-20 4.59 6.68 3.12 8.42 4.44 6.01 1.08 2.92 0.76 3.25 2.59 2.82 1.11 1.97 1.34 2.10 1.15 1.45 2.20 2.56 0.24 5.56 0.47 3.18 3.89 3.46 4.97 7.90 4.17 6.11
4 2024-01-27 4.37 8.22 2.60 9.04 4.89 6.41 1.16 2.78 0.64 3.12 1.77 2.55 1.56 2.35 1.18 1.83 1.11 1.49 2.11 2.71 0.23 5.19 0.55 3.05 5.19 2.63 3.92 7.86 3.79 6.09
5 2024-02-03 5.02 8.94 3.02 9.79 6.06 6.94 1.45 2.70 0.48 3.48 1.70 2.39 1.62 2.44 1.57 1.93 1.36 1.62 2.27 2.96 0.25 5.70 0.58 3.34 5.10 3.20 2.83 8.49 4.55 6.84
6 2024-02-10 6.26 9.97 3.86 9.89 6.16 6.98 1.56 2.68 0.51 2.89 1.57 2.19 1.84 2.14 1.44 1.74 1.25 1.51 2.54 3.73 0.42 5.57 0.65 3.48 6.80 2.64 3.01 8.57 3.48 6.75
7 2024-02-17 6.18 9.87 4.46 8.95 6.00 7.04 1.54 2.63 0.44 3.20 1.42 2.11 1.22 2.31 1.52 1.61 1.30 1.51 2.82 4.41 0.44 6.05 1.45 3.96 7.73 3.14 3.24 8.02 4.35 6.52
8 2024-02-24 6.21 9.55 6.31 8.35 5.20 6.94 1.84 2.55 0.73 3.21 1.31 2.25 1.30 2.86 1.85 2.00 1.38 1.66 3.15 4.29 0.53 5.74 1.19 4.19 8.28 3.07 3.67 8.29 4.21 6.61
9 2024-03-02 6.48 9.77 7.80 9.03 5.73 7.75 2.40 3.07 0.60 3.35 1.41 2.44 1.65 2.75 1.90 1.92 1.09 1.40 3.92 4.72 0.40 6.42 1.87 4.46 7.09 3.41 3.32 8.01 5.09 6.87
10 2024-03-09 6.52 9.42 8.24 10.16 5.53 8.08 2.74 2.77 0.68 4.18 1.19 2.69 1.31 2.79 1.98 2.23 1.50 1.78 4.57 5.05 0.51 6.74 2.26 4.94 6.84 3.71 3.86 8.34 4.28 6.99
11 2024-03-16 6.67 8.77 8.97 9.45 7.15 8.22 3.43 3.48 0.66 4.58 1.35 3.00 1.29 2.39 1.88 2.32 1.23 1.69 4.88 5.07 0.59 7.94 2.52 4.87 7.18 3.70 3.25 8.02 4.35 6.23
12 2024-03-23 6.63 9.31 9.52 10.26 8.58 9.63 4.18 2.98 1.05 4.95 1.26 3.33 1.44 2.60 1.71 2.13 1.82 1.96 4.59 5.40 0.77 6.69 3.65 5.35 6.74 4.50 4.38 6.99 3.95 5.67
13 2024-03-30 7.22 8.35 8.49 12.58 7.69 10.26 4.48 3.17 1.39 5.21 1.48 3.68 1.59 2.51 2.30 2.12 1.37 1.70 5.02 4.79 1.28 6.90 3.95 5.27 5.88 4.04 4.45 8.16 3.65 5.46

Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Figure 3

Note: Differences in positivity between jurisdictions can reflect differences in testing practices. Please interpret with caution.

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Week Week end Can Tests SARS-CoV-2% Atl Tests SARS-CoV-2% QC Tests SARS-CoV-2% ON Tests SARS-CoV-2% Pr Tests SARS-CoV-2% BC Tests SARS-CoV-2% Terr Tests SARS-CoV-2%
35 2023-09-02 25656 14.40 2110 16.92 9351 16.30 6230 12.39 5192 10.59 2651 18.03 122 11.48
36 2023-09-09 28237 15.92 2346 20.20 10215 17.37 6939 15.46 5968 11.90 2640 16.70 129 17.05
37 2023-09-16 31790 16.49 2567 18.62 11678 18.11 7337 15.66 6948 12.12 3111 20.64 149 10.07
38 2023-09-23 36264 18.60 2775 18.38 13455 20.48 8514 18.38 7969 14.23 3377 22.59 174 10.34
39 2023-09-30 40587 19.59 3126 22.65 15431 21.30 9291 17.86 8658 15.65 3895 23.59 186 12.90
40 2023-10-07 42173 19.81 3544 24.41 15684 22.19 9349 17.61 9198 15.96 4202 20.75 196 12.24
41 2023-10-14 38462 17.55 3583 20.74 12605 18.30 8426 15.27 9624 16.76 4047 19.13 177 14.69
42 2023-10-21 39350 17.78 3493 19.70 12590 18.63 9300 16.86 10040 17.16 3737 17.13 190 17.37
43 2023-10-28 37286 17.89 3095 17.74 12003 18.29 9276 19.35 9450 17.05 3262 14.87 200 17.50
44 2023-11-04 38183 17.74 2965 17.91 11975 18.42 9060 17.09 10341 18.12 3648 15.98 194 15.98
45 2023-11-11 38722 18.17 3122 20.12 11815 19.90 9607 18.24 10448 16.98 3545 14.41 185 10.81
46 2023-11-18 41432 18.80 3186 22.47 13182 20.21 10470 20.36 11134 16.80 3245 12.14 215 5.12
47 2023-11-25 42304 19.31 3490 22.35 12938 21.52 10880 22.17 11422 15.57 3385 11.96 189 6.35
48 2023-12-02 44713 18.03 3648 21.98 14100 22.18 11174 20.06 11903 12.58 3639 10.31 249 7.63
49 2023-12-09 46876 17.53 3654 20.17 14467 22.78 11644 18.67 12452 12.41 4272 10.30 387 6.98
50 2023-12-16 48215 17.78 4065 18.60 15835 23.97 12142 18.69 12089 11.16 3746 10.25 338 6.21
51 2023-12-23 48372 16.81 4353 15.81 16682 22.12 11548 18.73 11472 9.91 3952 10.55 365 9.86
52 2023-12-30 46997 15.35 4234 14.67 15739 19.65 11522 17.68 10314 9.95 4930 8.64 258 5.04
1 2024-01-06 48060 14.51 4471 12.68 15874 17.71 11545 16.83 10577 10.62 5300 9.57 293 7.17
2 2024-01-13 44189 13.03 4333 11.98 13921 14.75 11346 14.29 9475 9.91 4862 12.48 252 6.35
3 2024-01-20 38190 11.35 3750 10.64 11599 11.60 9942 12.87 8591 9.92 4141 10.92 167 4.19
4 2024-01-27 37089 10.19 3784 9.49 11052 9.79 9238 11.40 8358 8.95 4459 11.89 198 4.04
5 2024-02-03 36771 9.34 3908 8.75 10995 8.58 9011 9.75 8265 9.56 4420 10.63 172 5.81
6 2024-02-10 34740 8.79 3499 8.80 10544 7.33 8519 8.48 8042 10.12 3940 10.74 196 7.14
7 2024-02-17 35098 8.12 3185 8.92 11071 6.64 8901 7.48 8021 9.21 3722 11.04 198 7.07
8 2024-02-24 34145 7.49 3098 8.23 10925 5.10 8077 6.82 7890 8.66 3872 12.45 283 10.25
9 2024-03-02 33779 7.03 2992 7.02 10468 4.88 8299 6.21 7831 8.42 3972 11.76 217 6.45
10 2024-03-09 32484 6.24 3112 7.42 9479 3.46 7884 4.67 7845 7.71 3860 12.31 304 6.25
11 2024-03-16 32416 6.13 3346 6.90 9376 3.03 7702 5.47 7795 7.36 3904 11.63 293 7.51
12 2024-03-23 30990 5.17 3206 7.74 8603 2.26 7772 4.26 7547 6.15 3557 9.81 305 5.25
13 2024-03-30 29526 4.87 2831 6.85 8537 2.69 6962 4.28 7470 5.07 3454 9.18 272 7.35

Positive influenza (Flu) tests

Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Figure 4
Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Week Week end Can Tests Can A% Can B% Atl Tests Atl A% Atl B% QC Tests QC A% QC B% ON Tests ON A% ON B% Pr Tests Pr A% Pr B% BC Tests BC A% BC B% Terr Tests Terr A% Terr B%
35 2023-09-02 14543 0.69 0.06 984 0.00 0.00 3339 0.24 0.15 4324 0.39 0.09 3654 0.57 0.00 2158 2.46 0.00 84 2.38 0.00
36 2023-09-09 15430 0.43 0.06 1047 0.00 0.00 3649 0.19 0.03 4455 0.31 0.09 4069 0.37 0.05 2117 1.46 0.09 93 0.00 0.00
37 2023-09-16 18035 0.48 0.03 1216 0.08 0.00 4174 0.41 0.07 5145 0.29 0.00 4705 0.40 0.04 2703 1.29 0.04 92 0.00 0.00
38 2023-09-23 20121 0.51 0.02 1388 0.07 0.00 4734 0.30 0.00 5652 0.21 0.05 5325 0.62 0.02 2928 1.47 0.00 94 0.00 0.00
39 2023-09-30 21530 0.51 0.09 1403 0.14 0.07 4847 0.21 0.08 6186 0.37 0.11 5371 0.48 0.11 3598 1.36 0.06 125 0.00 0.00
40 2023-10-07 23658 0.64 0.05 1775 0.34 0.00 5628 0.37 0.04 6456 0.31 0.00 5803 0.74 0.16 3878 1.60 0.05 118 0.00 0.00
41 2023-10-14 23208 0.49 0.03 1938 0.57 0.00 4978 0.22 0.06 6283 0.30 0.00 6067 0.73 0.05 3828 0.73 0.03 114 0.00 0.00
42 2023-10-21 24067 0.73 0.08 2029 0.69 0.05 5110 0.37 0.02 6834 0.47 0.07 6370 1.13 0.13 3599 1.06 0.11 125 0.00 0.00
43 2023-10-28 23268 1.16 0.10 1979 0.96 0.00 5450 0.64 0.11 6814 0.50 0.06 5872 2.33 0.17 3039 1.45 0.10 114 0.88 0.00
44 2023-11-04 25317 2.63 0.10 1914 1.25 0.05 5705 0.63 0.07 6996 0.51 0.06 6996 6.80 0.17 3562 2.58 0.11 144 2.08 0.00
45 2023-11-11 26520 4.93 0.14 2069 2.03 0.14 5970 0.84 0.07 7240 1.22 0.07 7656 12.87 0.26 3460 3.96 0.14 125 4.00 0.00
46 2023-11-18 28583 7.24 0.16 2219 3.11 0.09 6454 1.36 0.09 7797 2.68 0.15 8734 18.14 0.26 3258 3.59 0.12 121 2.48 0.00
47 2023-11-25 29879 8.81 0.12 2521 4.60 0.04 6561 2.04 0.06 8070 2.69 0.02 9078 21.15 0.28 3517 6.43 0.09 132 15.15 0.00
48 2023-12-02 32859 11.62 0.26 2743 4.89 0.11 7199 3.78 0.15 8447 4.45 0.17 10485 24.44 0.47 3836 10.79 0.21 149 38.93 0.00
49 2023-12-09 34573 14.74 0.29 2817 9.66 0.11 8141 7.14 0.12 8466 7.08 0.21 11298 26.93 0.57 3590 13.12 0.11 261 49.81 0.00
50 2023-12-16 38612 15.32 0.36 3363 12.73 0.09 10087 11.63 0.12 9265 8.47 0.41 11116 24.56 0.71 4496 14.23 0.16 285 56.49 0.00
51 2023-12-23 40839 16.78 0.45 3820 19.08 0.31 12090 15.38 0.12 9246 11.39 0.51 10656 21.67 0.91 4747 16.64 0.29 280 40.36 0.00
52 2023-12-30 42482 18.18 0.52 3874 20.99 0.36 13501 19.37 0.07 9830 15.02 0.63 9720 17.61 1.26 5352 18.89 0.24 205 46.34 0.00
1 2024-01-06 43260 14.49 0.60 4132 17.91 0.36 13858 17.30 0.22 9869 11.67 0.54 9519 11.29 1.45 5634 14.55 0.39 248 33.47 0.00
2 2024-01-13 40233 11.16 0.56 3864 15.79 0.31 12702 15.32 0.19 9980 9.08 0.59 8491 5.94 1.33 4963 9.83 0.32 233 15.88 0.43
3 2024-01-20 35213 10.27 0.79 3422 14.23 0.94 11099 14.72 0.36 8812 8.65 0.45 7343 4.09 2.07 4397 9.71 0.34 140 5.71 0.00
4 2024-01-27 35174 11.10 1.08 3461 14.59 1.36 11277 17.65 0.28 8274 8.87 0.59 7261 2.31 2.91 4722 10.67 0.87 179 2.79 0.00
5 2024-02-03 35522 11.28 1.48 3608 14.61 2.02 12036 19.09 0.61 7738 8.30 1.02 7380 1.91 3.20 4626 8.58 1.25 134 2.24 2.99
6 2024-02-10 33997 10.37 1.74 3230 12.38 1.98 11857 18.01 1.05 7402 7.23 1.50 7230 1.77 3.28 4119 7.99 1.24 159 0.00 3.14
7 2024-02-17 33917 9.43 2.18 2882 8.78 2.74 11966 16.61 1.53 7689 7.40 1.87 7229 1.58 3.62 4006 6.81 1.40 145 1.38 11.03
8 2024-02-24 33294 8.01 3.17 2914 7.41 2.88 11748 14.22 2.63 7189 6.37 2.35 7030 1.07 5.65 4225 5.80 1.82 188 0.53 9.57
9 2024-03-02 32543 6.72 4.03 2834 7.13 4.13 11373 10.92 4.28 7133 5.72 2.90 6806 1.59 5.80 4231 5.25 1.96 166 2.41 13.25
10 2024-03-09 31700 5.55 5.12 2826 7.01 6.37 10775 8.84 5.27 6873 4.89 4.09 6835 1.29 6.63 4160 4.33 2.81 231 2.16 9.96
11 2024-03-16 30555 4.36 5.42 3170 6.03 4.95 9835 6.05 5.63 6948 3.94 3.80 6297 1.46 8.15 4077 4.42 3.63 228 0.44 8.77
12 2024-03-23 30093 3.27 5.71 3097 4.91 5.97 9038 3.75 5.18 6960 3.30 3.39 6918 1.45 9.35 3820 4.08 3.46 260 3.08 19.62
13 2024-03-30 27703 2.68 6.55 2909 3.82 7.25 9334 3.45 6.49 6384 2.44 3.29 6670 1.33 10.36 2178 2.85 2.16 228 0.88 21.49

Positive respiratory syncytial virus (RSV) tests

Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Figure 5
Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Week Week end Can Tests RSV% Atl Tests RSV% QC Tests RSV% ON Tests RSV% Pr Tests RSV% BC Tests RSV% Terr Tests RSV%
35 2023-09-02 13610 0.58 969 0.00 2540 1.14 4324 0.81 3535 0.20 2158 0.32 84 1.19
36 2023-09-09 14361 0.71 1047 0.57 2750 1.64 4455 0.88 3915 0.18 2101 0.24 93 0.00
37 2023-09-16 16808 0.82 1201 0.25 3181 1.67 5138 1.01 4494 0.38 2702 0.41 92 1.09
38 2023-09-23 18782 1.15 1381 1.30 3652 2.27 5652 1.43 5075 0.37 2928 0.51 94 0.00
39 2023-09-30 20217 1.14 1392 0.79 3788 2.38 6186 1.42 5128 0.43 3598 0.56 125 0.00
40 2023-10-07 22042 1.35 1761 0.28 4333 2.75 6456 1.95 5496 0.36 3878 0.72 118 0.00
41 2023-10-14 21748 1.80 1927 0.83 3897 3.70 6281 2.48 5701 0.63 3828 1.04 114 0.00
42 2023-10-21 22479 2.38 2015 0.69 3889 4.78 6834 3.72 6017 0.58 3599 1.25 125 0.00
43 2023-10-28 21745 3.25 1970 1.78 4234 6.24 6814 4.21 5574 1.22 3039 1.74 114 0.00
44 2023-11-04 23657 4.07 1904 2.15 4506 6.88 6997 5.80 6544 1.79 3562 2.36 144 2.78
45 2023-11-11 24764 5.12 2058 2.77 4680 7.97 7241 7.62 7201 2.14 3459 3.58 125 6.40
46 2023-11-18 26517 5.85 2195 2.41 4910 10.14 7796 7.91 8237 2.87 3258 4.27 121 7.44
47 2023-11-25 27491 6.81 2363 4.70 4975 11.82 8068 8.66 8508 3.24 3445 5.28 132 11.36
48 2023-12-02 30258 6.99 2549 5.88 5533 11.46 8447 8.49 9797 3.57 3783 6.66 149 8.72
49 2023-12-09 31232 7.38 2665 7.69 5930 11.11 8465 7.40 10436 4.53 3475 9.35 261 6.90
50 2023-12-16 34607 7.26 3004 8.46 7537 9.73 9261 5.99 10173 5.17 4347 9.50 285 10.53
51 2023-12-23 35988 7.29 3258 9.45 8774 9.14 9244 4.64 9820 6.47 4615 9.36 277 6.14
52 2023-12-30 37639 7.41 3431 8.57 9849 7.53 9829 4.62 9130 8.48 5196 9.49 204 15.69
1 2024-01-06 37934 7.10 3630 9.12 9953 7.31 9871 4.03 8828 7.56 5404 9.88 248 13.71
2 2024-01-13 35286 6.26 3383 9.16 9029 6.14 9975 3.27 7930 7.65 4737 7.81 232 17.67
3 2024-01-20 30827 6.13 2936 9.91 7837 5.82 8808 2.99 6892 8.21 4214 6.76 140 20.00
4 2024-01-27 30616 5.85 3067 10.01 7786 5.48 8260 2.62 6810 6.83 4514 7.35 179 24.02
5 2024-02-03 30446 5.91 3235 9.52 7985 5.07 7736 2.12 6932 8.18 4426 7.32 132 24.24
6 2024-02-10 29075 5.21 2949 10.07 7832 4.60 7404 1.62 6794 6.74 3937 6.27 159 20.75
7 2024-02-17 29028 4.49 2610 8.12 7969 4.56 7689 1.16 6769 6.04 3846 4.91 145 27.59
8 2024-02-24 28917 4.78 2715 7.18 8169 4.55 7189 1.14 6600 6.83 4057 5.57 187 29.41
9 2024-03-02 28626 3.79 2712 6.42 8150 3.99 7134 1.23 6368 4.35 4096 4.32 166 26.51
10 2024-03-09 27634 3.64 2700 6.52 7381 4.09 6873 0.89 6407 3.59 4043 3.96 230 33.91
11 2024-03-16 26585 3.18 3019 5.13 6559 3.58 6948 0.88 5896 3.43 3935 3.66 228 21.05
12 2024-03-23 26312 2.44 2944 3.53 6044 3.19 6961 0.49 6396 2.94 3707 2.81 260 7.69
13 2024-03-30 23940 2.32 2642 3.14 6380 3.71 6384 0.58 6254 2.16 2052 2.00 228 10.09

Positive human parainfluenza virus (HPIV) tests

Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Figure 6
Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HPIV% Atl Tests HPIV% QC Tests HPIV% ON Tests HPIV% Pr Tests HPIV% BC Tests HPIV%
35 2023-09-02 6234 1.99 362 1.38 847 3.90 3406 1.85 984 1.02 635 2.05
36 2023-09-09 6321 1.49 355 1.69 868 2.19 3420 1.43 1133 0.97 545 1.65
37 2023-09-16 7419 1.60 401 2.49 1053 2.18 3886 1.34 1326 1.06 753 2.66
38 2023-09-23 8139 1.77 430 2.79 1122 2.85 4366 1.74 1445 0.90 776 1.42
39 2023-09-30 8627 1.32 401 1.25 1117 1.88 4948 1.33 1415 1.06 746 0.94
40 2023-10-07 8791 1.34 467 3.43 1178 2.04 4850 1.20 1541 0.39 755 1.85
41 2023-10-14 8879 1.28 491 1.63 1094 1.37 4898 1.16 1638 1.04 758 2.24
42 2023-10-21 9281 1.59 498 2.21 1050 1.52 5293 1.51 1707 1.46 733 2.18
43 2023-10-28 9085 1.21 474 1.48 1063 1.98 5223 0.96 1656 0.85 669 2.69
44 2023-11-04 9496 1.44 492 2.24 1067 2.06 5215 1.00 1938 1.24 784 3.57
45 2023-11-11 9826 1.65 467 2.78 1257 1.83 5242 1.11 2076 1.35 784 5.10
46 2023-11-18 10441 1.39 500 2.20 1426 1.33 5505 1.24 2191 0.87 819 3.42
47 2023-11-25 10872 1.55 620 1.77 1442 1.04 5708 1.47 2195 1.18 907 3.53
48 2023-12-02 11676 1.51 676 2.37 1587 1.32 5967 1.39 2463 1.10 983 2.95
49 2023-12-09 11621 1.39 668 1.65 1630 1.10 6040 1.44 2537 1.14 746 2.14
50 2023-12-16 12631 1.46 730 1.92 1664 0.72 6696 1.36 2459 1.46 1082 2.96
51 2023-12-23 12648 1.35 768 1.56 1857 0.54 6421 1.46 2408 0.79 1194 3.02
52 2023-12-30 12871 1.35 709 1.55 2004 0.85 6809 1.29 2168 0.97 1181 3.13
1 2024-01-06 13434 1.48 812 1.72 2046 0.59 7059 1.60 2288 1.18 1229 2.69
2 2024-01-13 13182 1.17 924 1.73 1882 0.53 7137 1.16 2111 1.09 1128 1.95
3 2024-01-20 11423 1.08 704 1.28 1843 0.49 6099 1.18 1774 1.13 1003 1.30
4 2024-01-27 11007 1.16 834 0.72 1793 0.28 5677 1.41 1707 1.41 996 1.31
5 2024-02-03 11179 1.45 794 1.26 1833 0.55 5534 1.66 1933 1.86 1085 1.29
6 2024-02-10 10714 1.56 782 0.77 1832 0.49 5194 1.73 1937 1.55 969 3.30
7 2024-02-17 10731 1.54 619 1.29 1863 0.54 5369 1.42 1898 2.32 982 2.75
8 2024-02-24 10455 1.84 632 0.47 1825 1.59 5114 1.82 1905 2.20 979 2.55
9 2024-03-02 10419 2.40 587 1.02 1800 1.11 5157 2.83 1793 2.90 1082 2.40
10 2024-03-09 9897 2.74 483 2.69 1681 1.84 4982 2.65 1749 3.66 1002 3.09
11 2024-03-16 9750 3.43 626 1.92 1433 1.88 5071 3.45 1624 4.99 996 3.92
12 2024-03-23 9734 4.18 592 3.21 1332 2.55 5076 4.10 1810 4.92 924 6.17
13 2024-03-30 8781 4.48 581 3.96 1399 3.65 4574 4.59 1523 4.60 704 5.54

Positive adenovirus (ADV) tests

Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Figure 7
Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests ADV% Atl Tests ADV% QC Tests ADV% ON Tests ADV% Pr Tests ADV% BC Tests ADV%
35 2023-09-02 6238 1.62 362 1.93 851 2.70 3406 0.91 984 2.44 635 2.52
36 2023-09-09 6332 1.52 355 1.97 879 2.28 3420 0.82 1133 2.03 545 3.30
37 2023-09-16 7438 1.47 401 2.00 1071 2.43 3887 0.90 1326 1.96 753 1.86
38 2023-09-23 8149 0.93 429 1.17 1134 1.06 4365 0.62 1445 1.59 776 1.16
39 2023-09-30 8614 1.15 401 1.00 1129 2.04 4923 0.69 1415 1.63 746 2.01
40 2023-10-07 8809 1.41 467 2.36 1195 2.85 4851 0.66 1541 1.69 755 2.78
41 2023-10-14 8913 1.38 491 1.63 1111 3.42 4915 0.75 1638 1.47 758 2.11
42 2023-10-21 9286 1.43 498 1.20 1058 3.59 5292 0.76 1705 1.47 733 3.27
43 2023-10-28 9099 1.48 474 2.74 1077 3.62 5223 0.69 1656 1.63 669 2.99
44 2023-11-04 9514 1.76 492 2.03 1085 3.87 5215 1.04 1938 2.12 784 2.55
45 2023-11-11 9843 1.45 467 2.57 1274 2.98 5242 0.92 2076 1.64 784 1.40
46 2023-11-18 10452 2.03 500 4.60 1437 4.31 5505 0.94 2191 1.92 819 4.03
47 2023-11-25 10920 1.90 620 2.74 1461 3.97 5712 1.07 2194 1.50 911 3.84
48 2023-12-02 11737 2.15 676 3.25 1613 3.84 5967 1.36 2462 2.03 983 3.05
49 2023-12-09 11699 1.83 668 2.84 1652 3.75 6041 1.18 2537 1.26 746 3.62
50 2023-12-16 12719 2.00 730 2.19 1681 3.09 6696 1.78 2459 1.67 1082 2.40
51 2023-12-23 12035 1.55 768 1.82 1875 2.61 5726 0.89 2408 1.45 1194 3.02
52 2023-12-30 10983 1.76 709 2.12 2010 2.49 4852 0.80 2167 1.43 1181 4.74
1 2024-01-06 11675 1.48 812 1.11 2050 2.20 5219 0.75 2288 1.14 1229 4.15
2 2024-01-13 12078 1.25 924 1.52 1901 2.31 5943 0.59 2111 1.33 1126 2.49
3 2024-01-20 11461 1.11 704 1.56 1851 1.19 6091 0.64 1774 1.35 1003 2.89
4 2024-01-27 11062 1.56 834 2.88 1807 2.32 5675 0.78 1706 1.64 996 3.41
5 2024-02-03 11223 1.62 794 2.90 1841 2.55 5534 0.74 1933 1.55 1085 3.59
6 2024-02-10 10761 1.84 782 3.45 1852 2.59 5192 0.67 1935 1.45 969 5.88
7 2024-02-17 10779 1.22 619 1.29 1875 1.97 5369 0.60 1898 1.16 982 2.95
8 2024-02-24 10525 1.30 632 2.06 1837 2.01 5114 0.80 1905 0.89 979 2.96
9 2024-03-02 10484 1.65 587 4.26 1822 2.25 5157 1.01 1793 1.06 1082 2.87
10 2024-03-09 9989 1.31 483 1.86 1708 1.70 4982 0.78 1748 1.54 1002 2.30
11 2024-03-16 9808 1.29 626 1.44 1458 1.99 5072 0.79 1623 1.48 996 2.41
12 2024-03-23 9800 1.44 592 1.35 1358 1.62 5076 1.18 1809 1.00 924 3.46
13 2024-03-30 8826 1.59 581 2.07 1421 2.89 4574 0.87 1523 0.85 704 4.83

Positive human metapneumovirus (HMPV) tests

Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Figure 8
Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HMPV% Atl Tests HMPV% QC Tests HMPV% ON Tests HMPV% Pr Tests HMPV% BC Tests HMPV%
35 2023-09-02 6260 0.34 362 0.00 848 1.42 3407 0.21 1008 0.10 635 0.16
36 2023-09-09 6354 0.39 355 0.28 867 1.38 3423 0.20 1164 0.26 545 0.37
37 2023-09-16 7455 0.39 401 0.50 1053 0.76 3886 0.36 1362 0.07 753 0.53
38 2023-09-23 8194 0.38 429 0.00 1124 1.07 4365 0.14 1500 0.13 776 1.42
39 2023-09-30 8680 0.51 401 0.25 1118 0.89 4948 0.36 1467 0.34 746 1.34
40 2023-10-07 8828 0.32 457 0.44 1180 0.76 4853 0.14 1583 0.32 755 0.66
41 2023-10-14 8911 0.37 484 0.00 1096 1.00 4915 0.20 1658 0.12 758 1.32
42 2023-10-21 9321 0.46 498 0.20 1050 1.33 5298 0.32 1742 0.17 733 1.09
43 2023-10-28 9083 0.46 474 0.63 1066 1.41 5200 0.31 1674 0.18 669 0.75
44 2023-11-04 9519 0.55 492 0.20 1070 1.96 5218 0.17 1955 0.61 784 1.15
45 2023-11-11 9825 0.60 467 0.21 1256 2.15 5244 0.21 2074 0.63 784 0.89
46 2023-11-18 10315 0.79 500 0.40 1426 2.38 5505 0.36 2180 0.37 704 2.56
47 2023-11-25 10920 1.00 620 0.97 1442 2.57 5715 0.44 2210 0.59 911 2.96
48 2023-12-02 11703 0.91 676 0.89 1585 2.33 5965 0.47 2458 0.49 983 2.34
49 2023-12-09 11654 1.20 668 1.20 1635 2.39 6037 0.61 2513 1.95 746 0.94
50 2023-12-16 12683 1.31 730 1.78 1669 2.52 6707 0.63 2424 1.61 1082 2.77
51 2023-12-23 12659 1.59 768 1.56 1857 2.48 6415 0.78 2361 2.50 1194 2.85
52 2023-12-30 12881 1.76 709 2.26 2006 2.14 6809 0.98 2112 2.27 1181 4.49
1 2024-01-06 13431 2.20 812 1.85 2048 2.15 7012 1.07 2253 3.99 1229 5.78
2 2024-01-13 13207 1.64 924 1.41 1887 1.59 7144 0.62 2053 3.85 1126 4.26
3 2024-01-20 11426 2.20 704 1.56 1837 2.34 6103 1.23 1741 4.19 1003 4.79
4 2024-01-27 11026 2.11 834 1.92 1793 1.78 5678 1.13 1681 4.34 996 4.82
5 2024-02-03 11160 2.27 794 2.39 1831 2.46 5534 1.36 1880 2.87 1085 5.44
6 2024-02-10 10709 2.54 782 2.94 1828 2.63 5191 1.58 1908 2.62 969 7.12
7 2024-02-17 10757 2.82 619 2.91 1864 3.70 5376 2.14 1880 1.91 982 6.62
8 2024-02-24 10425 3.15 632 3.96 1825 2.79 5113 2.62 1818 2.31 979 7.76
9 2024-03-02 10398 3.92 587 3.75 1802 4.99 5157 3.37 1727 2.49 1082 7.30
10 2024-03-09 9915 4.57 483 5.38 1677 5.66 4991 4.49 1696 1.83 1002 7.58
11 2024-03-16 9742 4.88 626 7.67 1433 5.65 5084 4.76 1570 2.04 996 7.13
12 2024-03-23 9692 4.59 592 5.57 1333 5.33 5085 4.90 1717 1.75 924 6.71
13 2024-03-30 8732 5.02 581 7.40 1395 6.74 4585 4.73 1444 1.73 704 8.38

Positive enterovirus/rhinovirus (EV/RV) tests

Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Figure 9
Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests EV/RV% Atl Tests EV/RV% QC Tests EV/RV% ON Tests EV/RV% Pr Tests EV/RV% BC Tests EV/RV%
35 2023-09-02 5345 12.50 362 20.72 N.A. N.A. 3409 10.44 966 14.60 608 15.79
36 2023-09-09 5414 14.85 355 25.35 N.A. N.A. 3423 12.80 1119 16.80 516 17.05
37 2023-09-16 6331 18.29 401 23.69 N.A. N.A. 3887 16.08 1314 22.37 722 19.81
38 2023-09-23 6991 20.25 429 27.51 N.A. N.A. 4365 17.11 1428 25.14 747 24.63
39 2023-09-30 7479 18.52 401 26.43 N.A. N.A. 4948 15.74 1398 22.17 715 25.31
40 2023-10-07 7559 17.45 467 23.55 N.A. N.A. 4853 14.77 1515 20.99 706 23.80
41 2023-10-14 7762 15.74 491 23.01 N.A. N.A. 4915 13.77 1612 16.00 717 23.15
42 2023-10-21 8204 13.12 498 22.09 N.A. N.A. 5298 10.82 1681 13.50 695 22.16
43 2023-10-28 7977 12.52 474 16.03 N.A. N.A. 5227 9.95 1624 15.58 637 23.23
44 2023-11-04 8385 10.83 492 17.07 N.A. N.A. 5218 8.39 1916 12.21 736 20.52
45 2023-11-11 8530 10.70 467 16.70 N.A. N.A. 5244 8.68 2051 10.48 743 21.53
46 2023-11-18 8958 8.64 500 14.20 N.A. N.A. 5506 6.79 2161 8.42 779 18.87
47 2023-11-25 9427 7.62 620 11.94 N.A. N.A. 5716 5.86 2186 7.55 883 15.63
48 2023-12-02 10068 6.79 676 9.76 N.A. N.A. 5970 5.19 2427 6.47 959 15.43
49 2023-12-09 9980 6.00 668 6.74 N.A. N.A. 6046 4.50 2516 6.20 695 17.70
50 2023-12-16 11005 5.90 730 7.81 N.A. N.A. 6708 4.62 2437 4.97 1059 14.45
51 2023-12-23 10800 5.56 768 6.51 N.A. N.A. 6434 3.73 2380 5.88 1154 14.47
52 2023-12-30 10881 4.71 709 5.50 N.A. N.A. 6808 3.30 2155 4.83 1145 12.31
1 2024-01-06 11366 4.80 812 4.43 N.A. N.A. 7012 3.76 2268 5.51 1197 9.69
2 2024-01-13 11322 4.43 924 4.22 N.A. N.A. 7146 3.20 2090 5.07 1089 11.48
3 2024-01-20 9564 4.59 704 4.26 N.A. N.A. 6103 3.16 1751 6.40 968 10.02
4 2024-01-27 9212 4.37 834 4.68 N.A. N.A. 5678 3.12 1695 6.02 961 8.43
5 2024-02-03 9317 5.02 794 5.54 N.A. N.A. 5534 3.27 1918 7.66 1035 9.08
6 2024-02-10 8831 6.26 782 8.82 N.A. N.A. 5191 4.26 1909 7.54 918 12.42
7 2024-02-17 8854 6.18 619 6.30 N.A. N.A. 5376 4.35 1882 8.29 941 12.01
8 2024-02-24 8644 6.21 632 5.85 N.A. N.A. 5113 4.99 1896 7.23 945 10.69
9 2024-03-02 8601 6.48 587 6.30 N.A. N.A. 5157 4.65 1773 7.61 1041 13.74
10 2024-03-09 8230 6.52 483 9.11 N.A. N.A. 4991 4.81 1734 7.55 956 12.45
11 2024-03-16 8300 6.67 626 6.55 N.A. N.A. 5084 5.39 1593 7.34 964 12.03
12 2024-03-23 8413 6.63 592 7.26 N.A. N.A. 5085 5.45 1795 7.30 900 11.56
13 2024-03-30 7384 7.22 581 8.61 N.A. N.A. 4585 5.15 1507 9.62 688 14.53

Positive human coronavirus (HCoV) tests

Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Figure 10
Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HCoV% Atl Tests HCoV% QC Tests HCoV% ON Tests HCoV% Pr Tests HCoV% BC Tests HCoV%
35 2023-09-02 5054 0.28 362 0.00 847 0.47 2230 0.13 1007 0.60 608 0.16
36 2023-09-09 5195 0.42 355 0.56 868 0.81 2285 0.09 1171 0.77 516 0.39
37 2023-09-16 6174 0.23 401 0.50 1053 0.47 2636 0.23 1362 0.00 722 0.14
38 2023-09-23 6796 0.46 429 0.00 1122 0.80 2995 0.40 1503 0.40 747 0.54
39 2023-09-30 7026 0.28 401 0.00 1117 0.45 3325 0.21 1468 0.48 715 0.14
40 2023-10-07 7305 0.26 467 0.21 1178 0.08 3390 0.18 1587 0.25 683 1.02
41 2023-10-14 7435 0.32 491 0.20 1094 0.73 3461 0.12 1672 0.60 717 0.14
42 2023-10-21 7697 0.17 498 0.20 1050 0.48 3707 0.05 1747 0.23 695 0.14
43 2023-10-28 7576 0.38 473 0.42 1065 0.38 3707 0.30 1694 0.53 637 0.47
44 2023-11-04 7754 0.37 476 0.21 1067 0.28 3508 0.43 1967 0.20 736 0.82
45 2023-11-11 8119 0.42 467 0.86 1187 0.51 3607 0.28 2115 0.38 743 0.81
46 2023-11-18 8674 0.65 500 0.20 1324 0.98 3838 0.42 2233 0.99 779 0.51
47 2023-11-25 9069 0.65 620 0.65 1357 0.96 3977 0.55 2232 0.54 883 0.91
48 2023-12-02 9880 0.76 676 0.74 1518 1.05 4241 0.42 2486 0.72 959 1.88
49 2023-12-09 9440 1.12 668 1.20 1523 1.64 4007 0.57 2547 1.33 695 2.30
50 2023-12-16 10458 1.47 730 0.41 1583 1.58 4616 1.47 2470 1.58 1059 1.79
51 2023-12-23 10483 1.77 768 1.30 1765 2.10 4389 1.66 2407 1.58 1154 2.43
52 2023-12-30 10328 2.48 709 1.55 1885 2.97 4422 2.49 2167 2.08 1145 2.97
1 2024-01-06 10903 3.06 812 2.96 1861 2.10 4722 3.37 2311 2.81 1197 3.93
2 2024-01-13 10891 3.19 924 3.03 1719 2.50 5030 3.14 2129 3.85 1089 3.31
3 2024-01-20 9527 3.89 704 5.11 1698 4.18 4360 3.78 1797 3.78 968 3.20
4 2024-01-27 9111 5.19 834 5.28 1640 5.49 3941 5.76 1735 4.27 961 3.95
5 2024-02-03 9137 5.10 794 4.79 1647 5.10 3717 6.27 1944 3.34 1035 4.44
6 2024-02-10 8766 6.80 782 5.37 1653 9.50 3456 7.00 1957 5.01 918 6.21
7 2024-02-17 8846 7.73 619 6.30 1700 8.12 3661 8.96 1925 6.39 941 5.95
8 2024-02-24 8546 8.28 632 7.28 1644 10.28 3416 8.17 1909 7.02 945 8.47
9 2024-03-02 8590 7.09 587 6.47 1643 7.49 3511 8.32 1808 5.53 1041 5.38
10 2024-03-09 8072 6.84 483 4.97 1522 6.96 3342 8.02 1769 5.48 956 5.96
11 2024-03-16 8007 7.18 626 4.95 1287 7.30 3476 8.20 1654 6.83 964 5.39
12 2024-03-23 7947 6.74 592 6.08 1200 5.75 3452 7.42 1803 6.60 900 6.22
13 2024-03-30 7176 5.88 581 6.54 1269 4.96 3107 6.50 1531 4.90 688 6.40

Page details

Date modified: